Holen Sie sich die Stockscreener-App
22.94
4.27%
0.94
Handel nachbörslich:
22.94
Schlusskurs vom Vortag:
$22.00
Offen:
$22.24
24-Stunden-Volumen:
916.19K
Relative Volume:
0.85
Marktkapitalisierung:
$1.97B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
36.41
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
-2.26%
1M Leistung:
+9.34%
6M Leistung:
+6.80%
1J Leistung:
-17.45%
1-Tages-Spanne:
$21.98
$22.99
1-Wochen-Bereich:
$21.83
$23.60
52-Wochen-Spanne:
$13.39
$29.65
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
22.94 | 2.01B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
282.14 | 272.67B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
294.80 | 80.96B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
61.64 | 81.42B | 378.96B | 5.28B | 5.94B | 4.19 |
|
ELV
Elevance Health Inc
|
276.45 | 76.58B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
223.43 | 27.45B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny Stock Gains 3.1% Amid Market Rally and Earnings OptimismNews and Statistics - IndexBox
Why Progyny (PGNY) Stock Is Up Today - TradingView
What analysts say about Progyny Inc. stockUnstoppable investment returns - Autocar Professional
Progyny Inc. Stock Analysis and ForecastTriple returns potential - jammulinksnews.com
What drives Progyny Inc. stock priceDynamic investment growth - jammulinksnews.com
Is Progyny Inc. a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com
Why Progyny (PGNY) Stock Is Falling Today - Yahoo Finance
Truist Securities Maintains Hold Rating on Progyny (PGNY), Raise - GuruFocus
Progyny (PGNY) Price Target Increased Amid Mixed Investor Sentim - GuruFocus
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com Nigeria
Where are the Opportunities in (PGNY) - news.stocktradersdaily.com
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny rises on guidance update - MSN
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitori - GuruFocus
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitoring | PGNY Stock News - GuruFocus
Progyny partners with Oura for women’s health monitoring - Investing.com Australia
Progyny Partners with ?URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause | PGNY Stock News - GuruFocus
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - The Manila Times
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Truist Financial Keeps Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
BTIG Keeps Their Buy Rating on Progyny (PGNY) - The Globe and Mail
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Yahoo Finance
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance By Investing.com - Investing.com South Africa
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com Nigeria
Leerink Partners upgrades Progyny stock rating to Outperform on improved membership activity - Investing.com Canada
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Sector Update: Health Care - MarketScreener
Progyny stock rises as BofA reiterates Buy rating on better-than-expected Q2 - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook By Investing.com - Investing.com South Africa
Progyny (PGNY) Expects to Surpass Q2 2025 Projections - GuruFocus
Progyny expects Q2 results above previous forecast; shares gain - TradingView
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny stock (PGNY) rises: what’s going on with Progyny Inc? - Markets.com
Progyny Expects Q2 Results 'Slightly Above' Guidance, Enters $200 Million Revolver; Shares Rise - MarketScreener
Progyny stock rises on guidance update (PGNY:NASDAQ) - Seeking Alpha
Progyny Reveals $200 Mln Revolving Credit Facility, Sees Q2 Results Slightly Ahead Of Expectations - Nasdaq
Progyny, Inc. Enters into A Revolving Credit Facility - MarketScreener
Progyny, Inc. Provides Business Update and Announces Details for - GuruFocus
Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results - Nasdaq
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | PGNY Stock News - GuruFocus
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - The Manila Times
(PGNY) Proactive Strategies - news.stocktradersdaily.com
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
3.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):